Rahul Khanna1, Krutika Jariwala, John P Bentley. 1. Department of Pharmacy Administration, School of Pharmacy, The University of Mississippi , Faser Hall Room 236, PO Box 1848, University, MS, 38677, USA , rkhanna@olemiss.edu.
Abstract
PURPOSE: This study aimed to ascertain the psychometric properties of EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in primary caregivers of children with autism. The convergent validity, discriminant validity, known-groups validity, internal consistency reliability, and floor and ceiling effects of EQ-5D-3L were analyzed. METHODS: A cross-sectional design was used for study purposes. Through an online survey, relevant study information was collected from 316 primary caregivers of children with autism. Study participants were from families of children with autism living in the United States who were registered with the Interactive Autism Network. Convergent validity of the EQ-5D-3L was assessed through its correlation with other measures of similar constructs. Discriminant validity was assessed by observing the correlation of EQ-5D-3L domains with theoretically unrelated constructs. Known-groups validity was tested by comparing EQ-5D-3L index and visual analog scale (VAS) scores across levels of autism severity among the care recipients. Internal consistency reliability of EQ-5D-3L was tested. Lastly, floor and ceiling effects of EQ-5D-3L were assessed. RESULTS: More than 60 % of participants reported problems of 'anxiety/depression.' Convergent and discriminant validity of the EQ-5D-3L was good. Significant correlation (convergent validity) was observed among EQ-5D-3L index and VAS and (SF-12v2) physical component summary and mental component summary scores. Caregivers' EQ-5D-3L index and VAS scores varied by levels of autism severity among care recipients, providing evidence of known-groups validity. Reliability assessed through Cronbach's alpha was less than satisfactory; however, corrected item-total correlations were adequate. CONCLUSIONS: The EQ-5D-3L is a psychometrically sound tool to elicit health state preferences among caregivers of children with autism.
PURPOSE: This study aimed to ascertain the psychometric properties of EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in primary caregivers of children with autism. The convergent validity, discriminant validity, known-groups validity, internal consistency reliability, and floor and ceiling effects of EQ-5D-3L were analyzed. METHODS: A cross-sectional design was used for study purposes. Through an online survey, relevant study information was collected from 316 primary caregivers of children with autism. Study participants were from families of children with autism living in the United States who were registered with the Interactive Autism Network. Convergent validity of the EQ-5D-3L was assessed through its correlation with other measures of similar constructs. Discriminant validity was assessed by observing the correlation of EQ-5D-3L domains with theoretically unrelated constructs. Known-groups validity was tested by comparing EQ-5D-3L index and visual analog scale (VAS) scores across levels of autism severity among the care recipients. Internal consistency reliability of EQ-5D-3L was tested. Lastly, floor and ceiling effects of EQ-5D-3L were assessed. RESULTS: More than 60 % of participants reported problems of 'anxiety/depression.' Convergent and discriminant validity of the EQ-5D-3L was good. Significant correlation (convergent validity) was observed among EQ-5D-3L index and VAS and (SF-12v2) physical component summary and mental component summary scores. Caregivers' EQ-5D-3L index and VAS scores varied by levels of autism severity among care recipients, providing evidence of known-groups validity. Reliability assessed through Cronbach's alpha was less than satisfactory; however, corrected item-total correlations were adequate. CONCLUSIONS: The EQ-5D-3L is a psychometrically sound tool to elicit health state preferences among caregivers of children with autism.
Authors: Claire A G Wolfs; Carmen D Dirksen; Alfons Kessels; Daniëlle C M Willems; Frans R J Verhey; Johan L Severens Journal: Health Qual Life Outcomes Date: 2007-06-14 Impact factor: 3.186
Authors: Ashley A Leech; Pei-Jung Lin; Brittany D'Cruz; Susan K Parsons; Tara A Lavelle Journal: Appl Health Econ Health Policy Date: 2022-08-23 Impact factor: 3.686
Authors: D A Schmid; J H J Allum; M Sleptsova; A Welge-Lüssen; R Schaefert; G Meinlschmidt; W Langewitz Journal: Health Qual Life Outcomes Date: 2020-06-26 Impact factor: 3.186
Authors: Clare C Brown; J Mick Tilford; Nalin Payakachat; D Keith Williams; Karen A Kuhlthau; Jeffrey M Pyne; Renske J Hoefman; Werner B F Brouwer Journal: Pharmacoeconomics Date: 2019-04 Impact factor: 4.981
Authors: Leontine W Ten Hoopen; Pieter F A de Nijs; Jorieke Duvekot; Kirstin Greaves-Lord; Manon H J Hillegers; Werner B F Brouwer; Leona Hakkaart-van Roijen Journal: J Autism Dev Disord Date: 2021-11-01
Authors: Leontine W Ten Hoopen; Pieter F A de Nijs; Jorieke Duvekot; Kirstin Greaves-Lord; Manon H J Hillegers; Werner B F Brouwer; Leona Hakkaart-van Roijen Journal: J Autism Dev Disord Date: 2020-01